Zotiraciclib citrate, CAS [[1204918-73-9]] Preis auf Anfrage

Produktübersicht

• Artikelname: Zotiraciclib citrate, CAS [[1204918-73-9]] Preis auf Anfrage
• Artikelnummer: TGM-T202626
• Hersteller Artikelnummer: T202626
• Alternativnummer: TGM-T202626-10MG,TGM-T202626-50MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien

Produktbeschreibung

Zotiraciclib (also known as TG02 and SB1317) is an innovative small-molecule compound with potent inhibitory effects on CDK, JAK2, and FLT3. By inhibiting cyclin-dependent kinase 9 (CDK9) and depleting Myc, it serves as a treatment for cancers that can penetrate the blood-brain barrier. Zotiraciclib is one of the numerous CDK inhibitors under investigation, other compounds targeting CDK9, utilized for treating acute myeloid leukemia, include alvocidib and atuveciclib. Myc overexpression is a known factor in many cancers, with 80% of glioblastomas exhibiting this characteristic.

Produkteigenschaften

• Molekulargewicht: 564.59
• CAS Nummer: [1204918-73-9]
• Formel: C29H32N4O8

Bilder

T202626